KLÖCKNER PENTAPLAST ANNOUNCES MAJOR PHARMA CAPACITY EXPANSION IN COTIA TO SUPPORT GROWING MARKETS

Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) announces a 5 million Euro investment in their Cotia, Brazil facility. kp will expand capacity at its Brazilian location to enable new products to be manufactured in the region.

This content was submitted directly to this website by the supplier.

Klöckner Pentaplast’s Pharmaceutical & Medical Device Films Division (kp Pharma) announces a 5 million Euro investment in their Cotia, Brazil facility. kp will expand capacity at its Brazilian location to enable new products to be manufactured in the region.

Tracey Peacock, President, Pharmaceutical & Medical Device Films at kp, said: “We are seeing substantial growth in our high barrier product segments in South America in response to the increased temperature, moisture and oxygen sensitivity of new drugs. We are excited to support this key mega trend by adding significant capacity and technical capability to support new products into our Cotia facility”.
This latest investment comes about 2 years after the addition of the fourth slitting line in Cotia, which
increased the current site’s slitting capacity by ~4.000 tons per year.

We expect the new capability to be operational from July 2019 with the “simple aim of improving service to our customers wherever they are located in the South American region”; Tracey Peacock concluded. If you are interested in learning more about the company and our products come and visit our team at FCE Pharma, booth N021 during 22-24 May 2018, in São Paulo, Brazil.

For more information, click here

More in Home